2-Naphthaleneacetamide, N-(5-cyclopropyl-1H-pyrazol-3-yl)- manufacturers
- PNU-292137
-
- $2500.00
-
2026-05-11
- CAS:326823-27-2
- Purity:
- Supply Ability: 10g
|
| | 2-Naphthaleneacetamide, N-(5-cyclopropyl-1H-pyrazol-3-yl)- Basic information |
| | 2-Naphthaleneacetamide, N-(5-cyclopropyl-1H-pyrazol-3-yl)- Chemical Properties |
| Boiling point | 621.7±50.0 °C(Predicted) | | density | 1.343±0.06 g/cm3(Predicted) | | pka | 13.44±0.10(Predicted) |
| | 2-Naphthaleneacetamide, N-(5-cyclopropyl-1H-pyrazol-3-yl)- Usage And Synthesis |
| Uses | PNU-292137 is an orally active, potent CDK2 inhibitor with IC50s of 37 nM and 92 nM for CDK2/cyclin A and CDK2/cyclin E, respectively. PNU-292137 makes interactions with the hydrophobic pocket at the back of the CDK2 ATP pocket. PNU-292137 efficiently inhibits tumor cell proliferation in human colon and prostate tumor cell lines. PNU-292137 exhibits antitumor activity (TGI>50%) in a mouse xenograft model[1]. | | IC 50 | CDK2/cyclinA: 37 nM (IC50); CDK2/cyclin E: 92 nM (IC50); Cdk5/p25: 114 nM (IC50); CDK1/cyclinB: 270 nM (IC50); CDK4/cyclinD1: >10000 nM (IC50); GSK-3β: 1905 nM (IC50); ERK-2: 4600 nM (IC50) | | References | [1] Paolo Pevarello, et al. 3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead finding. J Med Chem. 2004 Jun 17;47(13):3367-80. DOI:10.1021/jm031145u |
| | 2-Naphthaleneacetamide, N-(5-cyclopropyl-1H-pyrazol-3-yl)- Preparation Products And Raw materials |
|